key: cord-0817976-z0r7nbk1 authors: Bellani, Giacomo; Cecconi, Maurizio; Grasselli, Giacomo title: Reply: Can We Reliably Predict the Failure of Noninvasive Ventilation in COVID-19–associated Acute Hypoxemic Respiratory Failure? date: 2021-03-30 journal: Ann Am Thorac Soc DOI: 10.1513/annalsats.202103-398le sha: 30cab697d2c81e376b2a0c233d4fe0d1a6b4d9cb doc_id: 817976 cord_uid: z0r7nbk1 nan We thank Dr. Avdeev and colleagues for their interest in our article (1) and for their comments, which allow us to clarify some points. Their main concern has to do with the prognostic value of the arterial oxygen tension (Pa O 2 )/fraction of inspired oxygen (FI O 2 ) ratio. First, we would like to emphasize the reliability of the FI O 2 even in noninvasive condition; despite the (most likely) presence of leaks, positive pressure will cause a unidirectional gas flow from the inner of the interface (face mask or helmet) toward the ambient pressure. Hence, there is no risk of room air contamination of the fresh gas flow mixture (2). This might not be the case in patients treated with high-flow nasal cannulas, who indeed may inhale room air (especially if breathing with an open mouth), but these patients were not included in our analysis. Regarding the threshold value of the Pa O 2 /FI O 2 ratio, we agree that this is somewhat arbitrary and that the chance of noninvasive FI O 2 . At the same time, the 150-mm Hg threshold is gaining increasing value in the literature in both invasively (3) and noninvasively ventilated patients (4, 5) and could provide a pragmatic guideline, particularly useful in these pandemic times. Irrespective of any a priori hypothesis, our data showed a robust association with outcome. Regarding the paper by Franco and colleagues (6), Avdeev only focuses on the patients with a Pa O 2 /FI O 2 ratio in the 100-200-mm Hg interval, but if one considers the entire population, mortality was 30% versus 21% under or above the 150-mm Hg threshold. Regarding the lower mortality observed in the nice study by Nightingale and colleagues (7), this was recorded in a much younger population than ours (52 vs. 68 years old), whereas the study from Brusasco and colleagues (8) did not include patients not eligible for resuscitation (as opposed to our study, in which 28% of patients had a do-not-intubate decision). Moreover, the baseline Pa O 2 /FI O 2 reported in both articles was collected before continuous positive airway pressure (CPAP) initiation; because CPAP rapidly and significantly improves Pa O 2 /FI O 2 (9), as also shown in Table 1 by Avdeev and coworkers, the severity of the populations is not comparable with ours. Very interestingly, the article by Avdeev and coworkers shows a difference (albeit statistically nonsignificant) between success and failure in the values of Pa O 2 /FI O 2 only if these were measured during NIV as opposed to during standard oxygen. This is totally in line with a recent finding by Coppadoro and colleagues (9) and emphasizes that Pa O 2 /FI O 2 has a prognostic value for NIV failure only if measured during NIV. At the same time, we fully agree with Avdeev, Yaroshetskiy, and Nuralieva (10) that the risk of patient self-inflicted lung injury is of paramount importance during NIV, and their finding on the role of minute ventilation is extremely relevant. This, unfortunately, was not measured in our study because of the predominant use of helmets, which do not allow this measurement. Moreover, when our study was designed (mid-March 2020), the evidence on the crucial role of coagulopathy in coronavirus disease (COVID-19) was still emerging, and, unfortunately, we did not collect D-dimers. It would have been an extremely interesting finding. In summary, we believe that Pa O 2 /FI O 2 , if measured during NIV, remains a key element to predict NIV failure or success, but it must be combined with indexes of patient self-inflicted lung injury and inflammatory and coagulation markers. COVID-19 Lombardy ICU Network. Noninvasive ventilatory support of patients with COVID-19 utside the intensive care units Why COVID-19 silent hypoxemia is baffling to physicians Feasibility and clinical impact of out-of-ICU noninvasive respiratory support in patients with COVID-19-related pneumonia Is continuous positive airway pressure (CPAP) a new standard of care for type 1 respiratory failure in COVID-19 patients? A retrospective observational study of a dedicated COVID-19 CPAP service Galliera CPAP-COVID-19 Study Group. Continuous positive airway pressure in COVID-19 patients with moderate-to-severe respiratory failure Noninvasive ventilation for acute hypoxemic respiratory failure in patients with COVID-19 COVID-19 Lombardy ICU Network. Noninvasive ventilatory support of patients with COVID-19 utside the intensive care units Reply: Can We Reliably Predict the Failure of Noninvasive Ventilation in COVID-19-associated Acute Hypoxemic Respiratory Failure? References COVID-19 Lombardy ICU Network. Noninvasive Ventilatory Support of COVID-19 Patients Outside the Intensive Care Units The use of helmets to deliver non-invasive continuous positive airway pressure in hypoxemic acute respiratory failure Reclassifying Acute Respiratory Distress Syndrome LUNG SAFE Investigators; ESICM Trials Group. Noninvasive Ventilation of Patients with Acute Respiratory Distress Syndrome. Insights from the LUNG SAFE Study Non-invasive ventilation for acute hypoxemic respiratory failure: intubation rate and risk factors Feasibility and clinical impact of out-of-ICU noninvasive respiratory support in patients with COVID-19-related pneumonia Is continuous positive airway pressure (CPAP) a new standard of care for type 1 respiratory failure in COVID-19 patients? A retrospective observational study of a dedicated COVID-19 CPAP service Galliera CPAP-Covid-19 study group. Continuous positive airway pressure in COVID-19 patients with moderate-to-severe respiratory failure Helmet CPAP to treat hypoxic pneumonia outside the ICU: an observational study during the COVID-19 outbreak Can We Reliably Predict the Failure of Non-invasive Ventilation in COVID-19-associated Acute Hypoxemic Respiratory Failure?